Virus News and Research

Latest Virus News and Research

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice.

21 Apr 2022

Antibody dependent cellular cytotoxicity may influence HIV transmission from mother to child during breastfeeding

Antibody dependent cellular cytotoxicity may influence HIV transmission from mother to child during breastfeeding

According to new research from Boston Medical Center, the antibody function known as antibody dependent cellular cytotoxicity (ADCC) and the ADCC sensitivity of HIV strains may influence the transmission of HIV from mother to child during breastfeeding.

21 Apr 2022

RNA splicing abnormalities in COVID-19 patients

RNA splicing abnormalities in COVID-19 patients

This study entailed the integration of multiple-omics datasets to examine the dysregulation in the host splicing mechanism and alteration in protein isoforms among COVID-19 patients.

20 Apr 2022

Advancements in HIV science

Advancements in HIV science

As far as viruses go, human immunodeficiency virus (HIV) is quite simple. About 100,000 times smaller than a red blood cell, the virus expresses just a dozen proteins, yet it can establish a lifelong infection that, if left untreated, causes acquired immunodeficiency syndrome (AIDS) and death.

20 Apr 2022

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

20 Apr 2022

Investigating the impact of SARS-CoV-2 Omicron spike mutations

Investigating the impact of SARS-CoV-2 Omicron spike mutations

Researchers investigated the impact of amino acid substitutions of SARS-CoV-2 Omicron on spike protein function, processing, and neutralization susceptibility.

20 Apr 2022

Study investigates co-metabolism during SARS-CoV-2 infection

Study investigates co-metabolism during SARS-CoV-2 infection

In a new study, researchers investigated host-virus co-metabolism during a SARS-CoV-2 infection.

20 Apr 2022

Persistent loss of smell after COVID-19 associated with altered olfactory epithelial gene expression

Persistent loss of smell after COVID-19 associated with altered olfactory epithelial gene expression

Researchers performed histology of the olfactory epithelium for smell loss measurements in patients with post-acute sequelae of SARS-CoV-2 infection.

20 Apr 2022

CAR T-Cell Therapy: The Future of Cancer and HIV Treatment?

CAR T-Cell Therapy: The Future of Cancer and HIV Treatment?

In this interview, News-Medical speaks to Professor Jun Huang about CAR T-cell therapy and its future as a potential treatment for cancer or HIV.

20 Apr 2022

Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

Researchers demonstrated ocular tropism of SARS-CoV-2 through neuronal invasion in transgenic mice with hACE2 expression.

20 Apr 2022

Nurses on the frontlines faced psychological and physical demands during COVID-19 pandemic

Nurses on the frontlines faced psychological and physical demands during COVID-19 pandemic

A new study from researchers at DePaul University's School of Nursing documents the emotions of 100 nurses who cared for patients during the early days of the COVID-19 pandemic.

20 Apr 2022

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.

20 Apr 2022

UCLA research finds "Long COVID" in 30% of people treated for COVID-19

UCLA research finds "Long COVID" in 30% of people treated for COVID-19

New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as "Long COVID."

19 Apr 2022

Racism may partly contribute to high cancer burden impacting Asian Americans

Racism may partly contribute to high cancer burden impacting Asian Americans

The Journal of the National Cancer Institute published a commentary today on the significant cancer disparities facing Asian Americans.

19 Apr 2022

Study: Almost 40% of New York City parents are hesitant to vaccinate children for COVID-19

Study: Almost 40% of New York City parents are hesitant to vaccinate children for COVID-19

Almost 40 percent of New York City parents are hesitant to vaccinate their young children for COVID-19, according to a new study by researchers at the CUNY Graduate School of Public Health and Health Policy.

19 Apr 2022

Vertical transmission of SARS-CoV-2 uncommon

Vertical transmission of SARS-CoV-2 uncommon

A new study shows that SARS-CoV-2 infection is not typically transferred to newborns from infected mothers, and if such transmission occurs, the resulting disease is usually mild.

19 Apr 2022

Wearables can identify changes in physiological systems during COVID-19 disease progression

Wearables can identify changes in physiological systems during COVID-19 disease progression

If you become ill with COVID-19, your smartwatch can track the progression of your symptoms, and could even show how sick you become.

19 Apr 2022

Novel approach to identify targets for Wolbachia-based dengue control

Novel approach to identify targets for Wolbachia-based dengue control

Dengue is the most widespread mosquito-borne disease in the world, and to date, there are no medical treatments for people suffering from this disease.

19 Apr 2022

Fully vaccinated HIV patients may be less susceptible to develop severe breakthrough SARS-CoV-2 infection

Fully vaccinated HIV patients may be less susceptible to develop severe breakthrough SARS-CoV-2 infection

A new study found that the risk of severe breakthrough infection of SARS-CoV-2 is low among fully vaccinated HIV patients.

19 Apr 2022

Researchers investigate Zika virus and Dengue virus co-immunity

Researchers investigate Zika virus and Dengue virus co-immunity

In a new study, researchers successfully created new strains of the Zika virus and proved that the process of passaging through mice resulted in significantly increased virulence.

19 Apr 2022

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.